(600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Obtaining Drug Registration Certificate by Subsidiary
Filed with SSE · Stock code 600535 · · 2 pages · Chinese
Summary by 6ix AI
Tasly Pharmaceutical Group Co. Ltd. announced that its subsidiary, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., has obtained a drug registration certificate for an injectable medication.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Tasly Pharmaceutical Group Co. Ltd. on 6ix
Story so far
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Obtaining the Drug Clinical Trial Approval Notice
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Election of Employee Director
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026
Earlier from Tasly Pharmaceutical
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Obtaining the Drug Clinical Trial Approval Notice
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Election of Employee Director
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
Follow Tasly Pharmaceutical into a list and get an email when it puts out news.
Follow Tasly Pharmaceutical